de la Cruz Maxine, Fan Joanna, Yennu Sriram, Tanco Kimberson, Shin SeongHoon, Wu Jimin, Liu Diane, Bruera Eduardo
MD Anderson Cancer Center, University of Texas, Houston, TX, USA,
Support Care Cancer. 2015 Aug;23(8):2427-33. doi: 10.1007/s00520-015-2610-3. Epub 2015 Jan 24.
Delirium is one of the most common neuropsychiatric complications in advanced cancer patients with a frequency of up to 85 % before death. It is associated with adverse clinical outcomes such as increased morbidity and mortality as well as significant family and patient distress. The aim of our study is to determine at the frequency of missed delirium (MD) and identify factors associated with MD.
Seven hundred seventy-one consecutive palliative care inpatient consults from August 1, 2009 to January 31, 2010 were reviewed. Demographics, Memorial Delirium Assessment Scale (MDAS), Edmonton Symptom Assessment Scale (ESAS), primary referral symptom, Eastern Cooperative Oncology Group (ECOG), and physician diagnosis of delirium were collected along with delirium etiology, subtype, and reversibility. Delirium was diagnosed with a MDAS score of ≥ 7 or by a palliative medicine specialist using Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Text Revision (DSM-IV TR) Criteria. MD was reported in those patients found to have delirium by the palliative medicine specialists but were referred by the primary team for other reasons besides delirium. Chi-squared test and Wilcoxon-Mann-Whitney test were used to examine the difference on measurements among or between different groups. Univariate logistic regression model was applied to assess for associations for MD.
Two hundred fifty-two (33 %) had a diagnosis of delirium by the palliative medicine specialist. One hundred fifty-three (61 %) were missed by the primary referring team. Females comprised 53 % (n = 81), white 62 % (n = 95), and pain was the most common referral symptom (n = 77, 50 %). Hypoactive delirium was the most common subtype of delirium in MD (n = 47, 63 %). Opioid-related delirium was the most common etiology of MD (n = 47, 31 %). Patients referred for pain were more likely to have MD (odds ratio (OR) = 2.57, p = 0.0109). Of the 82 patients with delirium that was reversed, 67 % (n = 55) had a diagnosis of MD.
Sixty-one percent of patients with a diagnosis of delirium by a palliative care specialist were missed by the primary referring team. Patients with MD were frequently referred for pain. Universal screening of cancer patients for delirium is recommended.
谵妄是晚期癌症患者中最常见的神经精神并发症之一,在死亡前出现的频率高达85%。它与不良临床结局相关,如发病率和死亡率增加,以及严重的家庭和患者痛苦。我们研究的目的是确定漏诊谵妄(MD)的频率,并识别与MD相关的因素。
回顾了2009年8月1日至2010年1月31日连续771例姑息治疗住院会诊病例。收集了人口统计学资料、纪念谵妄评估量表(MDAS)、埃德蒙顿症状评估量表(ESAS)、主要转诊症状、东部肿瘤协作组(ECOG)以及医生对谵妄的诊断,同时收集谵妄的病因、亚型和可逆性。谵妄的诊断依据为MDAS评分≥7分,或由姑息医学专家根据《精神疾病诊断与统计手册》第4版修订版(DSM-IV TR)标准进行诊断。MD是指那些经姑息医学专家诊断为谵妄,但因谵妄以外的其他原因由初级团队转诊的患者。采用卡方检验和Wilcoxon-Mann-Whitney检验来检验不同组之间或组内测量值的差异。应用单因素逻辑回归模型评估MD的相关性。
252例(33%)经姑息医学专家诊断为谵妄。初级转诊团队漏诊了153例(61%)。女性占53%(n = 81),白人占62%(n = 95),疼痛是最常见的转诊症状(n = 77,50%)。活动减退型谵妄是MD中最常见的谵妄亚型(n = 47,63%)。阿片类药物相关谵妄是MD最常见的病因(n = 47,31%)。因疼痛转诊的患者更易发生MD(比值比(OR)= 2.57,p = 0.0109)。在82例谵妄得到逆转的患者中,67%(n = 55)被诊断为MD。
初级转诊团队漏诊了61%经姑息治疗专家诊断为谵妄的患者。MD患者常因疼痛而转诊。建议对癌症患者进行谵妄的普遍筛查。